ACE and chronic kidney disease: Current treatment of patients with CKD most still relies mostly on an angiotensin-converting enzyme inhibitor (ACEI) and an angiotensin receptor blocker (ARB), however, these drugs only ameliorate, but not halt the progression of CKD to ESRD (Ruiz-Ortega et al., 2020).